New EU Competition Laws Threaten Licensing in Europe
Executive Summary
Biopharma industry beware. New anti-trust regulations due to come into force in Europe on May 1st 2004 may dramatically increase the time, cost and complexity of licensing, not only for European companies, but also any firm licensing products or technologies in Europe.